Fu-Bang Li1, Jie Chen, Jin-Dan Yu, Hui Gao, Ming Qi. 1. Department of Gastroenterology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Abstract
BACKGROUND: Alagille syndrome (AGS) is a rare or fatal disease affecting multiple systems including the liver, heart, eyes, skeleton and face. It has been considered a genetically heterogeneous disorder of the Notch signaling pathway. METHODS: A 28-month-old Chinese girl with congenital heart disease and jaundice was diagnosed with Alagille syndrome by liver biopsy showing a paucity of the intrahepatic bile ducts. Variants of the JAG1 gene were detected by DNA sequencing in the patient and her unaffected father. RESULTS: A heterozygous missense mutation was identified in exon 2 of the JAG1 gene in the proband but not in exon 2, 4, 6, 9, 17, 23, 24 by DNA sequencing in her father. The mutation G-->T change was seen at position 133 in the cDNA sequence (c.133 G-->T), causing a substitution of a leucine for a valine (V45L) residue in the N terminus between signal peptide and DSL domain of the Notch ligand. This mutation, however, was absent in her father. CONCLUSION: Genes in the Notch signaling pathway should be further studied in AGS, and used to confirm clinical or prenatal diagnosis and facilitate genetic counseling.
BACKGROUND:Alagille syndrome (AGS) is a rare or fatal disease affecting multiple systems including the liver, heart, eyes, skeleton and face. It has been considered a genetically heterogeneous disorder of the Notch signaling pathway. METHODS: A 28-month-old Chinese girl with congenital heart disease and jaundice was diagnosed with Alagille syndrome by liver biopsy showing a paucity of the intrahepatic bile ducts. Variants of the JAG1 gene were detected by DNA sequencing in the patient and her unaffected father. RESULTS: A heterozygous missense mutation was identified in exon 2 of the JAG1 gene in the proband but not in exon 2, 4, 6, 9, 17, 23, 24 by DNA sequencing in her father. The mutation G-->T change was seen at position 133 in the cDNA sequence (c.133 G-->T), causing a substitution of a leucine for a valine (V45L) residue in the N terminus between signal peptide and DSL domain of the Notch ligand. This mutation, however, was absent in her father. CONCLUSION: Genes in the Notch signaling pathway should be further studied in AGS, and used to confirm clinical or prenatal diagnosis and facilitate genetic counseling.
Authors: C Crosnier; C Driancourt; N Raynaud; S Dhorne-Pollet; N Pollet; O Bernard; M Hadchouel; M Meunier-Rotival Journal: Gastroenterology Date: 1999-05 Impact factor: 22.682
Authors: L Li; I D Krantz; Y Deng; A Genin; A B Banta; C C Collins; M Qi; B J Trask; W L Kuo; J Cochran; T Costa; M E Pierpont; E B Rand; D A Piccoli; L Hood; N B Spinner Journal: Nat Genet Date: 1997-07 Impact factor: 38.330
Authors: Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner Journal: Am J Hum Genet Date: 2006-05-10 Impact factor: 11.025
Authors: D M Warthen; E C Moore; B M Kamath; J J D Morrissette; P A Sanchez-Lara; P Sanchez; D A Piccoli; I D Krantz; N B Spinner Journal: Hum Mutat Date: 2006-05 Impact factor: 4.878